Introduction
Acinetobacter spp., particularly A. baurnannii, cause severe nosocomial infections, especially in intensive care units [l] . Such infections have become difficult to treat as many strains are now resistant to multiple antibiotics, including the aminoglycosides, third-generation cephalosporins and fluoroquinolones [2] . Resistance rates to all the clinically useful aminoglycosides are higher in Acinetobacter spp. than any other pathogen group [3] . There are various mechanisms by which bacteria can become resistant to aminoglycosides, including alteration of the ribosomal target site and reduction of uptake [4, 51; however, the production of aminoglycoside-modifying enzymes is thought to account for most resistance in clinical isolates of Acinetobacter spp. [3] . Three classes of aminoglycoside-modifying enzymes exist, all of which have been found in Acinetobacter spp. [ 5 ] . These enzymes are the O-nucleotidyltransferases (ANT) and O-pho sp hotransferase s ( APH) , that cat a1 y se , re spectively, the nucleotidylation (adenylation) and phosphorylation of the hydroxyl groups, and the N-acetyltransferases (AAC), that catalyse acetylation of amino groups, so rendering the antibiotic inactive. Hybridisation data have confirmed that some strains of Acinetobacter may contain several aminoglycoside resistance genes [3] .
Many factors influence the dissemination of antibiotic resistance genes. Although certain species of Acinetobacter have been shown to be intrinsically resistant to some aminoglycosides, resistance genes have also been found on plasmids, transposons and integrons [6-81. The rapid emergence of resistance to aminoglycosides in clinical isolates of this genus has been attributed to their ability to acquire these resistance determinants. However, studies to date have concentrated on identifying particular enzymes and genetic determinants involved in resistance and, except on a local scale, have not investigated the epidemiological relationships of the resistant strains themselves. The purpose of the present study was to determine whether specific mechanisms of aminoglycoside resistance have developed in particular strains from defined geographical locations (with subsequent clonal spread), or whether common resistance mechanisms have been acquired by genotypically distinct clinical isolates of Acinetobacter spp. throughout the world. To address this question, the genotypic and epidemiological relationships of the isolates in this study were correlated with the aminoglycoside-modifing enzymes produced by the isolates and the genetic location of the responsible resistance determinants.
Materials and methods

Bacteria
Twenty-four Acinetobacter isolates from 15 different hospitals in 11 countries were studied ( Table 1) . All had been identified previously to the genomic species level by the tDNA profile method [lo] and their genotypic relationships had been investigated by analysis of randomly amplified polymorphic DNA (RAPD) fingerprints obtained with M13 core region and DAF4 primers [9] . The isolates were stored at -70°C in Skim Milk Powder (Oxoid) 10% w/v in sterile distilled water and then subcultured on to Isosensitest Agar (Oxoid), containing appropriate selective aminoglycoside antibiotics, and incubated overnight at 30°C before analysis. The strains used in the plasmid transfer experiments were Escherichia coli K12 strain 553.2 (F-, pro, met, rif ') and a rifampicin-resistant mutant of A. baumannii type strain ATCC 19606.
Aminoglycoside resistance projles (AGRPs)
Resistance profiles of the 24 isolates to 14 different aminoglycoside antibiotics were determined by a modified disk inhibition zone method as described previously [ 1 11 . Disks (Sanofi Diagnostics Pasteur) contained the following antibiotics (pg/disk): kanamycin (30) , neomycin (30) , netilmicin (30) , tobramycin (lo), amikacin (30) , gentamicin (1 0), apramycin (1 00), fortimicin (loo), 6'-netilmicin (loo), 2'-netilmicin (1 00), isepamicin (30), 5 '-episisomicin (1 0), spectinomycin (25) and streptomycin (30) . Plates were incubated for 24 h at 30°C and the diameters of the inhibition zones were measured. Similarity coefficients were then calculated and subjected to cluster analysis by the DENDRON v.2.3a program (Solltech Inc., Oakdale, IA, USA). [9] to have a similarity coefficient (Sm) value of 372% following analysis of RAPD fingerprints.
Determination of aminoglycoside acetylating and adenylating activity
The method of Al-Asadi et al. [12] was used in conjunction with a cellulose phosphate paper-binding system [ 131 to determine the presence of aminoglycoside acetylating or adenylating activity in cell extracts. Suspensions of cells grown at 30°C in 50ml of Nutrient Broth (Oxoid) were harvested by centrifbgation at 4000 g for 15 min at 4°C and resuspended in 5 ml of Tris-HC1 buffer, pH 7.6. The cells were disrupted in an MSE ultrasonic disintegrator (6 X 30-s bursts at an amplitude of 15 pm, with 30 s between bursts) on ice. The resulting preparations were tested for their ability to bind radioactivity from 1-l4C-acetyl coenzyme A (Dupont) and 8-"C-adenosine triphosphate (Amersham International) to gentamicin, tobramycin, amikacin and kanamycin, as described previously [ 121. All tests were performed in duplicate on two occasions. Suitable facilities were not available for the determination of phosphorylating activity.
Detection of aminoglycoside resistance genes
Extraction of DNA. For extraction of whole-cell DNA, isolates were grown in nutrient broth overnight at 30°C, the cells were harvested by centrifugation at 8000 g for 10 min and the DNA was extracted with DNAzolTM (GibcoBRL) reagent, used according to the manufacturer's instructions. Portions (5 p1) of the resulting suspensions were applied to Nylon Plus Membranes (Qiagen, Crawley, W. Sussex) and the DNA was immobilised by exposure to W light (120 mJ/cm2 at 254 nm) in a W Stratalinker (Stratagene) on filter paper saturated with 10 X SSC (1 X SSC is 150 mM NaCI, 15 mM sodium citrate, pH 7.0). Intact chromosomal DNA and plasmid DNA were prepared in agarose plugs and separated by pulsed-field gel electrophoresis by the method of Curran et aE. [14] . Following electrophoresis, discrete bands of chromosomal and plasmid (if present) DNA were transferred to Nylon Plus Membranes and cross-linked as described previously [ 141.
DNA hybridisation. DNA immobilised on membranes was hybridised with biotin-labelled oligonucleotide probes for seven distinct genes encoding aminoglycoside resistance: aac (3) 
Plasmid transfer experiments
Conjugation experiments with the rifampicin-resistant and aminoglycoside-susceptible recipient strains of E. coli K12 and the type strain of A . baumannii were performed with a filter-mating method [24] and overnight incubation at 30°C. Possible transconjugants were selected on Isosensitest agar containing rifampicin 100 pg/ml and one of amikacin, gentamicin, kanamy-cin or tobramycin 10 pg/ml. Transfer fiequencies were expressed in terms of the number of transconjugants obtained/recipient cell.
Association of aminoglycoside resistance genes with integrons
The PCR was performed with primer sets comprising the 5'CS primer ( Table 2 ) specific for the 5' conserved sequence of Tn21-type integrons [25] and a primer for each individual aminoglycoside resistance gene ( Table  2) . Amplification conditions comprised 35 cycles of 1 min of denaturation at 94"C, 1 min of annealing at 55°C and 5min of extension at 72°C. PCR products were analysed on agarose 1.5% w/v gels and the sizes of any PCR products were determined by comparison with the distances migrated by pGEM DNA Markers (Promega) run on the same gel. Table 1 shows the sources and known genotypic relationships of the isolates included in the study, based on cluster analysis of RAPD fingerprints obtained with M13 and DAF4 primers, respectively [9] . Although some isolates (those in the same group) have a close genetic relationship, the overall collection of isolates was genotypically heterogeneous. The zones of inhibition of the various aminoglycosides for the clinical isolates and the sensitive type strain of A. baumannii are shown in Table 3 . All 24 clinical isolates were resistant to four or more aminoglycosides, with some exhibiting resistance to up to 11 of the 14 aminoglycosides tested (Table 3 ). Most were resistant to gentamicin, tobramycin, kanamycin, spectinomycin and streptomycin; however, all were relatively sensitive to apramycin. Fig. 1 shows the cluster analysis results obtained following analysis of the zones of inhibition. When compared with Table 1 , it was apparent that some closely related isolates fiom the same genotypic group were unrelated in terms of their resistance to aminoglycoside antibiotics, and vice versa. Thus, for example, isolates G1 and G5, which are related genotypically, are unrelated according to their AGRPs, but isolates CW22 and CW32, while not related Table 3 . 
Results
Comparison of aminoglycoside resistance projiles and genotypic relationships
(100) 
Characterisation of aminoglycoside-modihing activity
Also listed in Table 3 are the aminoglycoside acetylating and adenylating activities found in each individual isolate included in the study. By examining and comparing the AGRPs and the acetylating or adenylating activities of the isolates with those expected of known aminoglycoside-modifying enzymes, it was possible to deduce the probable enzyme content of the isolates [26] . On this basis, seven different enzymes were produced by the collection of isolates (Table 4 ). Most resistance could be attributed to the production of one or more enzymes, although one isolate had an unusual resistance pattern that was attributed, in part at least, to a change in permeability. The most common enzyme appeared to be ANT(3")-I (spectinomycin and streptomycin resistance), produced by 20 of the 24 isolates. AAC(3)-1 (gentamicin and fortimicin resistance) and ANT(2") (gentamicin, tobramycin and kanamycin resistance) also appeared to be common, being produced by 12 and eight isolates, respectively. These two enzymes were considered to be responsible for most of the gentamicin resistance within the collection of isolates. Other common enzymes were APH(3 ')-I and APH(3 ')-VI, produced by nine isolates each. The enzymes occurred in various combinations of between one and four enzymes in each isolate, with the combinations of ANT(3")-I with AAC(3)-1, and ANT(3")-I with APH(3')-VI occuring the most frequently (in 10 and nine isolates each, respectively). Table 4 also shows the results obtained following hybridisation with the specific gene probes that were available. All the isolates failed to hybridise with the aac(6')-Ia and ant(3'y-Ib probes. Those isolates that exhibited a putative ANT(3")-I profile all hybridised AAC ( 
Correlation of inferred aminoglycoside-modihing enzymes with hybridisation data
Location of aminoglycoside resistance genes
Transfer of aminoglycoside resistance from the clinical isolates to E. coli K12 was not detected (transfer frequency of < 2 X lo-''). However, of the 24 strains, nine transferred one or more resistances to a sensitive strain of A. baumannii at frequencies of between 5 X and 1.6 X lov4 ( Table 5 ). Hybridisation of DNA separated on pulsed-field gels with the available probes revealed that two ant(2'y-Ia genes were present on plasmids detected in two of the 24 isolates (isolates CW32 and A16), but DNA probes for 41 of the total of 55 genes detected were found to hybridise to the intact chromosome. The remaining 12 genes may have been located on plasmids that were not separated by pulsedfield gel electrophoresis;XeZd, nine were shown to be transferable in conjugation experiments ( Table 5 ). In addition, the location of the genes encoding resistance mediated by the APH(3')-I enzyme could not be deduced because of the lack of an available probe, PCR analysis with the 5'CS primer and the primer for the aac(3)-Ia gene yielded a product of 200 bp from six isolates ( Table 4 ). Three of these isolates also yielded a product of 2.7 kb with the 5'CS primer and that specific for the ant(3'Y-Ia gene (Table 4 ). However, the other isolates carrying the aac(3)-Ia or ant(3'y-la genes (six and 14 isolates respectively), did not yield integron-associated products. No other integron-associated products were detected with any of the other primer combinations investigated.
Discussion
The primary aim of this study was to investigate whether particular aminoglycoside-modifing enzymes produced by clinical isolates of Acinetobacter spp. had evolved in and were confined to specific genotypes of this genus (with subsequent clonal spread), or whether the same resistance mechanisms were being acquired independently by unrelated genotypes, and if so, the nature of the genetic processes involved. The isolates included in the study were obtained from worldwide locations and were known from a previous study [9] to be genotypically heterogeneous. However, based on the (Table 1) . When the cluster analysis results based on aminoglycoside inhibition zones ( Fig.  1) were compared with the genotypic groupings, it was apparent that isolates sharing the same AGRPs were found in different genotypic groups, indicating that the same resistance mechanisms may be shared by diverse groups of isolates.
To examine this point further, the aminoglycosidemodifying enzyme content of the various isolates was first deduced by analysis of the AGRPS and aminoglycoside-modifying activity found in cell extracts, and was then confirmed by the use of specific aminoglycoside gene probes. The hybridisation results were in complete agreement with the enzyme content inferred for each isolate from its AGW. Seven different enzymes were produced by the collection of isolates ( Table 4) , often in combination. AAC(3)-I and ANT(2"), found in several genotypic groups, were responsible for most of the gentamicin resistance observed. Similarly, the other five enzymes were also found in genotypically unrelated isolates. Thus, based on the limited number of isolates examined, it appeared from these results that the same aminoglycoside resistance genes were distributed amongst several genotypically distinct groups of isolates. Attempts to transfer resistance from the clinical isolates to E. coli were unsuccessful, but transfer of certain resistance genes was detected from nine isolates to a sensitive type strain of A. baumannii ( Table 5 ). Potential mobilisation of transposons from the chromosome of the resistant clinical isolates to other bacteria remains to be investigated, but the aac(3)-Ia and ant(3")-Ia genes were shown by PCR analysis to be associated with Tn2I-type integron structures in six isolates.
Integrons are novel genetic elements that include the determinants of a site-specific recombination system capable of capturing and mobilising genes that are contained in discrete mobile gene cassettes [28] . They are thought to be involved in the spread and formation of new combinations of antibiotic resistance determinants in a wide range of gram-negative bacteria [29] and can be located either on plasmids or can become stably inserted into the chromosome as part of transposition-type processes [30, 3 11 .
In conclusion, this study demonstrated that similar aminoglycoside-modifying enzymes are found in unrelated isolates of Acinetobacter spp. and that particular genes are not restricted to specific areas of the world. It seems that certain aminoglycoside resistance genes have become disseminated in Acinetobacter spp. by a range of genetic mechanisms, including transfer on plasmids and integron-type structures. Such genetic mechanisms have already been shown to be involved in the global dissemination of mercury-resistance amongst environmental isolates of Acinetobacter spp. [32] . The association of these various genetic structures with resistance to antibiotics other than aminoglycosides, and their importance in the dissemination of such resistance, remains to be determined.
